No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Narcolepsy Drug market is a subset of the Central Nervous System Drugs market. Narcolepsy is a neurological disorder characterized by excessive daytime sleepiness and sudden, uncontrollable episodes of sleep. Narcolepsy drugs are used to reduce the symptoms of the disorder, such as excessive daytime sleepiness, cataplexy, and sleep paralysis. These drugs are typically stimulants, such as modafinil, armodafinil, and methylphenidate. Other drugs used to treat narcolepsy include tricyclic antidepressants, sodium oxybate, and clonidine.
Some companies in the Narcolepsy Drug market include Cephalon, Inc., Teva Pharmaceuticals, Mylan Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more
